Almost a third of adults taking Wegovy® pill (oral semaglutide 25 mg) were early responders to treatment, achieving an ...

Novo Nordisk A/S NVO presented new analyses from its phase 3 OASIS 4 clinical trial at the European Congress on Obesity 2026 ...

Novo Nordisk has presented fresh data from the OASIS 4 trial at the European Congress on Obesity 2026, showing strong ...

Oral Ozempic and Wegovy pills are now available for same-day delivery on Amazon. Novo Nordisk CEO says more than one million ...

Eli Lilly and Novo Nordisk are building cases for their incretin drugs both new and old as attractive weight loss maintenance ...

People on weight loss jabs could maintain their progress by shifting to a daily pill after finishing treatment, a study ...

More than a quarter of obese people taking a daily pill version of the weight loss drug Wegovy responded swiftly to the ...

More than a quarter of obese people taking a daily pill version of the weight loss drug responded swiftly to the treatment ...

Novo Nordisk’s Wegovy pill is already providing financial fuel in the company’s bid to catch Eli Lilly.

Novo Nordisk’s higher dose Wegovy shows 28% weight loss in early responders according to new analyses: Bagsværd, Denmark Wednesday, May 13, 2026, 16:00 Hrs [IST] Novo Nordisk, ...

Q1 2026 pressure but guidance raised on Wegovy pill uptake. Low 12.5x P/E, risks vs. Lilly. Click for this NVO earnings ...